Suchergebnisse - (Subject:"Siltuximab")

PubPharm (49)

1

Long-Term Tolerance and Efficacy of Siltuximab (Anti-IL-6) in a Young Adult with Idiopathic Multicentric Castleman Disease During COVID-19

enthalten in: European journal of case reports in internal medicine | 2023

von Bedier, H. | Isnard, S. | Maedler-Kron, C. | +1

2

Long-term tolerance and efficacy of siltuximab (anti-IL-6) in a young adult with idiopathic multicentric Castleman disease during COVID-19

in: European Journal of Case Reports in Internal Medicine | 2023

von Helbies Bedier | Stéphane Isnard | Chelsea Maedler-Kron | +1

3

Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease

enthalten in: European journal of hospital pharmacy : science and practice | 2022

von Iluta, S. | Pasca, S. | Dima, D. | +7

4

Idiopathic Multicentric Castleman Disease Occurring Shortly after mRNA SARS-CoV-2 Vaccine

enthalten in: Vaccines | 2022

von Hoffmann, C. | Wechselberger, T. | Drexel, H. | +5

5

COVID-19 acute respiratory distress syndrome : A simulation study of the effects of combination therapy with tocilizumab and siltuximab

enthalten in: British journal of clinical pharmacology | 2022

von Doyle, E. | Bentley, D. | Dodds, M.

6

A New Approach to the Management of COVID-19. Antagonists of IL-6 : Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

7

Advances in clinical outcomes : What we have learned during the COVID-19 pandemic

enthalten in: The Journal of allergy and clinical immunology | 2022

von Al-Musa, A. | LaBere, B. | Habiballah, S. | +2

8

A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

9

A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

10

A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

1
2
3
4
5
Nächster »
[5]